Citation Impact
Citing Papers
In vivo imaging of hydrogen peroxide production in a murine tumor model with a chemoselective bioluminescent reporter
2010 StandoutNobel
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
2009 StandoutScience
Autonomic Nerve Development Contributes to Prostate Cancer Progression
2013 StandoutScience
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
The cellular physiology of carbonic anhydrases.
2001
Pharmacokinetics of the nonsteroidal steroid sulphatase inhibitor 667 COUMATE and its sequestration into red blood cells in rats
2004
Widespread, hypoxia‐inducible expression of HIF‐2α in distinct cell populations of different organs
2002 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Hypoxia — a key regulatory factor in tumour growth
2002 Standout
Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma
2003 StandoutNobel
Expression, Assay, and Structure of the Extracellular Domain of Murine Carbonic Anhydrase XIV
2004
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Involvement of Members of the Cadherin Superfamily in Cancer
2009
Cell Anchorage Regulates Apoptosis through the Retinoblastoma Tumor Suppressor/E2F Pathway
1997
About human tumor antigens to be used in immunotherapy
2008
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
2005 StandoutNature
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Induction of vascular endothelial growth factor and hypoxia-inducible factor-1α by global ischemia in rat brain
2000
Bcl-2 accelerates multistep prostate carcinogenesis in vivo
2000
The pro- and anti-inflammatory properties of the cytokine interleukin-6
2011 Standout
Mechanisms of apoptosis by c-Myc
1999
Hallmarks of aging: An expanding universe
2023 Standout
Bcl-2-dependent modulation of Ca2+ homeostasis and store-operated channels in prostate cancer cells
2002
Molecular determinants of resistance to antiandrogen therapy
2003 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Cellular survival: a play in three Akts
1999 Standout
Imaging angiogenesis of genitourinary tumors
2010
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
2005 StandoutNobel
Anti-angiogenic activity of inositol hexaphosphate (IP6)
2004
Neuropilin-2 and Neuropilin-1 Are Receptors for the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF) and of Placenta Growth Factor-2, but Only Neuropilin-2 Functions as a Receptor for the 145-Amino Acid Form of VEGF
2000
Functional Role of G9a Histone Methyltransferase in Cancer
2015
Apoptosis in cancer: from pathogenesis to treatment
2011 Standout
Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250
2000
Antisense therapy for cancer
2005
Androgen Receptor Signaling in Androgen-Refractory Prostate Cancer
2001
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
2013 Standout
Molecular genetics of prostate cancer
2000
Inhibition of Ca2+-Independent Phospholipase A2 Decreases Prostate Cancer Cell Growth by p53-Dependent and Independent Mechanisms
2008
Oncomirs — microRNAs with a role in cancer
2006 Standout
Differential prognostic impact of hypoxia induced and diffuse HIF-1α expression in invasive breast cancer
2005
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Resistance in the anti-angiogenic era: nay-saying or a word of caution?
2003
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
2005 StandoutNature
Cholinergic innervation and function in the prostate gland
2002
Co-delivery of VEGF and Bcl-2 dual-targeted siRNA polymer using a single nanoparticle for synergistic anti-cancer effects in vivo
2015
Fasting-mimicking diet blocks triple-negative breast cancer and cancer stem cell escape
2021
The relevance of a hypoxic tumour microenvironment in prostate cancer
2009
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Gold Nanoparticles for Biology and Medicine
2010 Standout
Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell
2001 Standout
Genetic Variation in the Hypoxia-Inducible Factor-1α Gene Is Associated with Type 2 Diabetes in Japanese
2005
Cancer-related inflammation: Common themes and therapeutic opportunities
2011
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis
2002 StandoutNobel
Angiogenesis as a therapeutic target
2005 StandoutNature
Uropathic Observations in Mice Expressing a Constitutively Active Point Mutation in the 5-HT3AReceptor Subunit
2004 StandoutNobel
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers
1998
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
Functional genomics approach to hypoxia signaling
2004
Metabolic reprogramming by HIF-1 promotes the survival of bone marrow–derived angiogenic cells in ischemic tissue
2011 StandoutNobel
Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
1998
Antisense Oligonucleotides: Promise and Reality
2001
Bcl-2-mediated alterations in endoplasmic reticulum Ca 2+ analyzed with an improved genetically encoded fluorescent sensor
2004 StandoutNobel
Mechanisms Underlying the Development of Androgen-Independent Prostate Cancer
2006
p53 MUTATIONS IN PROSTATE CANCER BONE METASTASES SUGGEST THAT SELECTED p53 MUTANTS IN THE PRIMARY SITE DEFINE FOCI WITH METASTATIC POTENTIAL
1999
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
2004 StandoutNobel
Integrin Signaling
1999 StandoutScience
Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation
2017 StandoutNobel
Combination therapy in combating cancer
2017 Standout
Ultrasensitive Immunosensor for Cancer Biomarker Proteins Using Gold Nanoparticle Film Electrodes and Multienzyme-Particle Amplification
2009
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
CYSTOMETRIC EVALUATION OF BLADDER FUNCTION IN NON-ANESTHETIZED MICE WITH AND WITHOUT BLADDER OUTLET OBSTRUCTION
2000
Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells
2001
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
GENETIC AND CELLULAR CHARACTERISTICS OF BLADDER OUTLET OBSTRUCTION
1995
Tumor‐associated Carbonic Anhydrases and Their Clinical Significance
2006
A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation
2001 StandoutNobel
Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration
2018 StandoutNobel
Hoxb13is required for normal differentiation and secretory function of the ventral prostate
2003 StandoutNobel
Stromal epigenetic dysregulation is sufficient to initiate mouse prostate cancer via paracrine Wnt signaling
2012
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation
2006 StandoutScience
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
A Phase II, Pharmacokinetic, and Biological Correlative Study of Oblimersen Sodium and Docetaxel in Patients with Hormone-Refractory Prostate Cancer
2005
Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
2005
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
2004 StandoutNobel
Induction of apoptosis by mifepristone and tamoxifen in human LNCaP prostate cancer cells in culture
2000
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications
2004
Works of Min‐Wei Chen being referenced
IL-6 Trans-Signaling in Formation and Progression of Malignant Ascites in Ovarian Cancer
2010
Bladder Function in Experimental Outlet Obstruction: Pharmacologic Responses to Alterations in Innervation, Energetics, Calcium Mobilization, and Genetics
1995
The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cells
2002
Reduction of wild type p53 function confers a hormone resistant phenotype on LNCaP prostate cancer cells*
2001
Expression of Messenger Ribonucleic Acid Splice Variants for Vascular Endothelial Growth Factor in the Penis of Adult Rats and Humans1
1999
Protocadherin-PC promotes androgen-independent prostate cancer cell growth
2006
Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells
2002
Human hormone-refractory prostate cancers can harbor mutations in the O 2 -dependent degradation domain of hypoxia inducible factor-1α (HIF-1α)
2002
An early molecular response induced by acute overdistension of the rabbit urinary bladder
1994
Expression of VEGF Splice Variants 144/145 and 205/206 in Adult Male Tissues
1999
The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis
2014
Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.
1995
Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells.
2003
Abnormal prostate development in C3(1)-bcl-2 transgenic mice
1997
CASTRATION INDUCES ACUTE VASOCONSTRICTION OF BLOOD VESSELS IN THE RAT PROSTATE CONCOMITANT WITH A REDUCTION OF PROSTATIC NITRIC OXIDE SYNTHASE ACTIVITY
1999
Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma.
1997